Skip to main content
. 2022 Jun 14;23(12):6630. doi: 10.3390/ijms23126630

Figure 3.

Figure 3

Structural characteristics of Proteolysis Targeting Chimeric molecules (PROTACs) currently in a clinical trial, distinguished by structural moiety and route of administration.